# Tulex Pharmaceuticals Inc., Cranbury, NJ – FDA Inspections

Source: https://www.keypedia.com/companies/tulex-pharmaceuticals-inc/e9839d9b-b973-49c3-916a-4ca187d606dd

> Inspection records and compliance data for Tulex Pharmaceuticals Inc. in Cranbury, New Jersey. 6 FDA inspections on record, 2 Form 483s, last inspected March 24, 2025.

---

## Details

- Name: Tulex Pharmaceuticals Inc.
- FEI Number: 3011875665
- Business Operations: FDF MANUFACTURE
- Address Line 1: 5 Cedarbrook Dr
- City: Cranbury
- State: New Jersey
- Zip Code: 08512
- Country Name: United States
- Address: 5 Cedarbrook Dr, Cranbury, New Jersey 08512, United States
- Country: United States

## Related Documents

- [483 - Tulex Pharmaceuticals Inc. - 2025-03-24](https://www.keypedia.com/records/483/tulex-pharmaceuticals-inc/a13a486c-928d-431f-847a-5d4f12d53869) — source: FDA, date: March 24, 2025
- [FDA Inspection 1264812 - Tulex Pharmaceuticals Inc. - 2025-03-24](https://www.keypedia.com/records/fda_inspections/tulex-pharmaceuticals-inc/3085aa66-b7a0-4815-9e58-5d1875897b55) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 24, 2025
- FDA Inspection 1256966 - Tulex Pharmaceuticals Inc. - 2024-12-05 — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 5, 2024
- FDA Inspection 1232755 - Tulex Pharmaceuticals Inc. - 2024-02-29 — classification: No Action Indicated (NAI), source: FDA, date: February 29, 2024
- FDA Inspection 1129002 - Tulex Pharmaceuticals Inc. - 2020-08-14 — classification: No Action Indicated (NAI), source: FDA, date: August 14, 2020
- [483 - Tulex Pharmaceuticals Inc. - 2019-12-12](https://www.keypedia.com/records/483/tulex-pharmaceuticals-inc/172155ac-360f-439f-b295-e3c9ea28aa8e) — source: FDA, date: December 12, 2019
- FDA Inspection 1053140 - Tulex Pharmaceuticals Inc. - 2018-04-05 — source: FDA, date: April 5, 2018
- [FDA Inspection 1031819 - Tulex Pharmaceuticals Inc. - 2017-11-21](https://www.keypedia.com/records/fda_inspections/tulex-pharmaceuticals-inc/a0867f8e-3b5f-4fc5-ad03-788d5b196185) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 21, 2017

## Related Companies

- [TOLMAR, Inc.](https://www.keypedia.com/companies/tolmar-inc/a73dea00-baea-4f0e-8234-c0becc61322e)
- [AbbVie Ltd](https://www.keypedia.com/companies/abbvie-ltd/b07cdd9b-e7d5-4b8b-b31d-3cc5dd0c3775)
- [Corium Innovations, Inc.](https://www.keypedia.com/companies/corium-innovations-inc/6ef69358-81bb-44a9-a576-41a1c5d94783)
- [Societal CDMO Gainesville, LLC](https://www.keypedia.com/companies/societal-cdmo-gainesville-llc/6a502520-0ac5-48a2-ac38-7b93e63598cb)
- [United Therapeutics Corporation](https://www.keypedia.com/companies/united-therapeutics-corporation/5f83ecf2-e9e1-408a-9a1b-b381eac864a1)
- [KVK Tech, Inc.](https://www.keypedia.com/companies/kvk-tech-inc/f8ea60fc-cfc0-4769-8e62-a677abd59cb9)
- [Sever Pharma Solutions](https://www.keypedia.com/companies/sever-pharma-solutions/d4aaa41d-8c80-4520-bc82-45ae10cb4795)
- [Eli Lilly Italia SPA](https://www.keypedia.com/companies/eli-lilly-italia-spa/fe932949-0f6d-4e17-8349-73b2b9e19e43)
- [Laboratorio Reig Jofre, S.A.](https://www.keypedia.com/companies/laboratorio-reig-jofre-sa/be0ced8d-3d5f-4d78-b23e-7fa32e4794b5)
- [NATURA BISSE INTERNATIONAL SA](https://www.keypedia.com/companies/natura-bisse-international-sa/52b93ce0-03c9-4c21-abb2-f4307ddaedbd)

## Related Officers

- [Adetutu M. Gidado](https://www.keypedia.com/people/adetutu-m-gidado/6c4e8cf3-0eea-4903-9ca5-e8e2d683621d)
- [Suchan Kim](https://www.keypedia.com/people/suchan-kim/1acf9a36-036f-48a8-a8a4-caa290830e37)
- [James R. Birkenstamm](https://www.keypedia.com/people/james-r-birkenstamm/eb1192a4-3c76-4243-886c-9b5805871ad1)
